SHSE:688016 (China)
Â
Class A
Â¥
103.33
(+5.65%)
Jul 2
Business Description
Shanghai Microport Endovascular Medtech Co Ltd
ISIN : CNE100003MJ5
Share Class Description:
SHSE:688016: Class ACompare
Compare
Traded in other countries / regions
688016.China IPO Date
2019-07-22Description
Shanghai Microport Endovascular Medtech Co Ltd is primarily engaged in the development, production and sales of medical devices for aortic and peripheral vascular interventions.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 96.69 | |||||
| Equity-to-Asset | 0.89 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | 0.05 | |||||
| Interest Coverage | 356.25 | |||||
| Piotroski F-Score | 8/9 | |||||
| Altman Z-Score | 18.55 | |||||
| Beneish M-Score | -2.22 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 36 | |||||
| 3-Year EBITDA Growth Rate | 32.1 | |||||
| 3-Year EPS without NRI Growth Rate | 34.2 | |||||
| 3-Year FCF Growth Rate | 24.2 | |||||
| 3-Year Book Growth Rate | 39.4 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 58.39 | |||||
| 9-Day RSI | 45.81 | |||||
| 14-Day RSI | 41.01 | |||||
| 6-1 Month Momentum % | -12.87 | |||||
| 12-1 Month Momentum % | -6.49 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 10.06 | |||||
| Quick Ratio | 9.49 | |||||
| Cash Ratio | 8.82 | |||||
| Days Inventory | 248.35 | |||||
| Days Sales Outstanding | 46.76 | |||||
| Days Payable | 56.34 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 3.07 | |||||
| Dividend Payout Ratio | 0.31 | |||||
| 3-Year Dividend Growth Rate | 52.4 | |||||
| Forward Dividend Yield % | 3.07 | |||||
| 5-Year Yield-on-Cost % | 3.07 | |||||
| 3-Year Average Share Buyback Ratio | -4.7 | |||||
| Shareholder Yield % | 3.08 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 76.63 | |||||
| Operating Margin % | 50.23 | |||||
| Net Margin % | 43.81 | |||||
| FCF Margin % | 36.33 | |||||
| ROE % | 20.39 | |||||
| ROA % | 17.92 | |||||
| ROIC % | 55.4 | |||||
| ROC (Joel Greenblatt) % | 152.36 | |||||
| ROCE % | 23.07 | |||||
| Years of Profitability over Past 10-Year | 8 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 21.06 | |||||
| PE Ratio without NRI | 20.71 | |||||
| Price-to-Owner-Earnings | 29.22 | |||||
| PEG Ratio | 0.64 | |||||
| PS Ratio | 9.18 | |||||
| PB Ratio | 3.15 | |||||
| Price-to-Tangible-Book | 3.46 | |||||
| Price-to-Free-Cash-Flow | 25.61 | |||||
| Price-to-Operating-Cash-Flow | 17.88 | |||||
| EV-to-EBIT | 14.05 | |||||
| EV-to-EBITDA | 14.05 | |||||
| EV-to-Revenue | 7.2 | |||||
| EV-to-FCF | 19.53 | |||||
| Price-to-Projected-FCF | 2.5 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.83 | |||||
| Price-to-Graham-Number | 1.79 | |||||
| Price-to-Net-Current-Asset-Value | 4.05 | |||||
| Price-to-Net-Cash | 4.72 | |||||
| Earnings Yield (Greenblatt) % | 7.12 | |||||
| FCF Yield % | 3.59 | |||||
| Forward Rate of Return (Yacktman) % | 21.99 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Shanghai Microport Endovascular Medtech Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 1,259.694 | ||
| EPS (TTM) (Â¥) | 4.906 | ||
| Beta | 1.06 | ||
| Volatility % | 34.1 | ||
| 14-Day RSI | 41.01 | ||
| 14-Day ATR (Â¥) | 3.906347 | ||
| 20-Day SMA (Â¥) | 106.3245 | ||
| 12-1 Month Momentum % | -6.49 | ||
| 52-Week Range (Â¥) | 94.83 - 141.140939 | ||
| Shares Outstanding (Mil) | 123.26 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Shanghai Microport Endovascular Medtech Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Shanghai Microport Endovascular Medtech Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Shanghai Microport Endovascular Medtech Co Ltd Frequently Asked Questions
What is Shanghai Microport Endovascular Medtech Co Ltd(SHSE:688016)'s stock price today?
The current price of SHSE:688016 is ¥103.33. The 52 week high of SHSE:688016 is ¥141.14 and 52 week low is ¥94.83.
When is next earnings date of Shanghai Microport Endovascular Medtech Co Ltd(SHSE:688016)?
The next earnings date of Shanghai Microport Endovascular Medtech Co Ltd(SHSE:688016) is .
Does Shanghai Microport Endovascular Medtech Co Ltd(SHSE:688016) pay dividends? If so, how much?
The Dividend Yield %  of Shanghai Microport Endovascular Medtech Co Ltd(SHSE:688016) is 3.07% (As of Today), Highest Dividend Payout Ratio of Shanghai Microport Endovascular Medtech Co Ltd(SHSE:688016) was 0.47. The lowest was 0.22. And the median was 0.3. The  Forward Dividend Yield % of Shanghai Microport Endovascular Medtech Co Ltd(SHSE:688016) is 3.07%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers